New Partnership to Accelerate Oncolytic Virus Therapy Genezen, a leading viral vector Contract Development and Manufacturing Organization (CDMO), and Humane Genomics, a biotechnology company focused on oncolytic viral therapies, announced a strategic manufacturing partnership to advance a new therapy for pediatric liver cancer. The collaboration combines Genezen’s manufacturing scale and regulatory compliance expertise with Humane…